GENFLEET-B(02595),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02595 GENFLEET-B

Trading 03-16 11:19:55

27.300

-2.120

-7.21%

High31.580	Low27.140	Vol1.70M
Open31.500	D1 Closing29.420	Amplitude15.09%
Mkt Cap10.10B	Tradable Cap9.23B	Total Shares370.00M
T/O50.70M	T/O Rate0.50%	Tradable Shares338.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"GENFLEET-B","latestPrice":27.3,"timestamp":1773631195634,"preClose":29.42,"halted":0,"volume":1699600,"delay":0,"changeRate":-0.07205982324949017,"floatShares":338000000,"shares":370000000,"eps":-26.20482,"marketStatus":"Trading","change":-2.12,"latestTime":"03-16 11:19:55","open":31.5,"high":31.58,"low":27.14,"amount":50702585,"amplitude":0.150918,"askPrice":27.38,"askSize":1200,"bidPrice":27.3,"bidSize":1400,"shortable":3,"etf":0,"ttmEps":-2.744,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1773633600000},"marketStatusCode":2,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":29.42,"openAndCloseTimeList":[[1773624600000,1773633600000],[1773637200000,1773648000000]],"volumeRatio":1.198389,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02595","defaultTab":"news","newsList":[{"id":"1116262730","title":"GENFLEET-B (02595) Schedules 24 Mar 2026 Board Meeting to Approve FY2025 Results and Final Dividend Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1116262730","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116262730?lang=en_us&edition=fundamental","pubTime":"2026-03-12 06:22","pubTimestamp":1773267756,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 02595), a joint-stock company incorporated in the PRC, has announced that its board of directors will convene on Tuesday, 24 March 2026. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"2618790989","title":"GenFleet Therapeutics to hold board meeting to approve annual results and consider final dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2618790989","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618790989?lang=en_us&edition=fundamental","pubTime":"2026-03-12 06:07","pubTimestamp":1773266852,"startTime":"0","endTime":"0","summary":"Genfleet will hold a board meeting on March 24, 2026 to consider and approve its annual results for the year ended December 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics  Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL49d1SN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595"],"gpt_icon":0},{"id":"1164081911","title":"GENFLEET-B Shares Surge Over 11% on Inclusion in Southbound Trading and Anticipated GFH375 Data Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1164081911","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164081911?lang=en_us&edition=fundamental","pubTime":"2026-03-09 10:10","pubTimestamp":1773022239,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) saw its shares rise more than 11%. At the time of writing, the stock was up 9.96% to HK$27.6, with a turnover of HK$40.0633 million. On the news front, on March 9, GENFLEET-B...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","BK4588","BK1574","02595","159938","09939","VT","BK4585","VXUS"],"gpt_icon":0},{"id":"1105349362","title":"GENFLEET-B (02595) Announces Inclusion in Stock Connect Program from March 9, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1105349362","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105349362?lang=en_us&edition=fundamental","pubTime":"2026-03-09 08:02","pubTimestamp":1773014568,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B, 02595) announced that, according to notices from the Shanghai Stock Exchange and the Shenzhen Stock Exchange, its shares will be included in the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"2618692639","title":"GenFleet Therapeutics Joins Hang Seng Index SeriesGenFleet Therapeutics (Shanghai) Inc. said it will be included in the Hang Seng Index Series from March 9, 2026, including the Hang Seng Composite Index, the Hang Seng Stock Connect Hong Kong Index, and the Hang Seng Innovative Drug Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2618692639","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618692639?lang=en_us&edition=fundamental","pubTime":"2026-03-09 08:01","pubTimestamp":1773014483,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics Joins Hang Seng Index Series GenFleet Therapeutics  Inc. said it will be included in the Hang Seng Index Series from March 9, 2026, including the Hang Seng Composite Index, the Hang Seng Stock Connect Hong Kong Index, and the Hang Seng Innovative Drug Index. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics  Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL5SLsQF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595"],"gpt_icon":0},{"id":"1104829936","title":"GENFLEET-B (02595) Announces Monthly Securities Movement Update for February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1104829936","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104829936?lang=en_us&edition=fundamental","pubTime":"2026-03-05 17:39","pubTimestamp":1772703588,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B, stock code: 02595) published its monthly return for the period ended 28 February 2026, detailing the status of both its Hong Kong-listed and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"2616066748","title":"GenFleet Therapeutics' GFH375 Granted Breakthrough Designation in China for Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2616066748","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616066748?lang=en_us&edition=fundamental","pubTime":"2026-03-02 10:47","pubTimestamp":1772419655,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics   said GFH375 was granted the breakthrough therapy designation in China as a treatment for a type of non-small cell lung cancer, according to a Hong Kong bourse filing Monday.The company is studying the medicine in patients with KRAS G12D-mutant non-small cell lung cancer patients who have received at least one prior systemic therapy.The company expects to announce data from ongoing studies of the medicine at global academic events this year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02595","BK4007","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2616080398","title":"BRIEF-GenFleet Therapeutics (Shanghai) Says GFH375 Granted First Breakthrough Therapy Designation In China","url":"https://stock-news.laohu8.com/highlight/detail?id=2616080398","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616080398?lang=en_us&edition=fundamental","pubTime":"2026-03-02 09:27","pubTimestamp":1772414861,"startTime":"0","endTime":"0","summary":"BRIEF-GenFleet Therapeutics  Says GFH375 Granted First Breakthrough Therapy Designation In ChinaMarch 2  - GenFleet Therapeutics  Inc 2595.HK:GFH375 GRANTED FIRST BREAKTHROUGH THERAPY DESIGNATION IN CHINA FOR A-KRAS G12D INHIBITORFurther company coverage: 2595.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZO04A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595"],"gpt_icon":0},{"id":"1148484961","title":"GenFleet Therapeutics (Shanghai) Inc. (2595) Announces Breakthrough Therapy Designation for KRAS G12D Inhibitor in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1148484961","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148484961?lang=en_us&edition=fundamental","pubTime":"2026-03-02 09:21","pubTimestamp":1772414516,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (GenFleet, 2595) reported that its oral KRAS G12D (ON/OFF) inhibitor GFH375 received Breakthrough Therapy Designation from the Center for Drug Evaluation of the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"1160117931","title":"GENFLEET-B's GFH375 Receives Breakthrough Therapy Designation in China for KRAS G12D-Mutant NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1160117931","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160117931?lang=en_us&edition=fundamental","pubTime":"2026-03-02 08:08","pubTimestamp":1772410107,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that its oral KRAS G12D (ON/OFF) inhibitor, GFH375, has been included in the Breakthrough Therapy Designation (BTD) list by the Center for Drug Evaluation (CDE) of the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","09939","BK1515","BK1161","BK1574","159938"],"gpt_icon":0},{"id":"2616779048","title":"China CDE Grants GenFleet’s GFH375 Breakthrough Therapy Designation for KRAS G12D NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2616779048","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616779048?lang=en_us&edition=fundamental","pubTime":"2026-03-02 08:02","pubTimestamp":1772409741,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics  Inc. said the Center for Drug Evaluation of China’s National Medical Products Administration granted Breakthrough Therapy Designation to its oral KRAS G12D inhibitor GFH375 for treating KRAS G12D-mutant non-small cell lung cancer patients who have received at least one prior systemic therapy. The company said the designation was supported by Phase I/II data from the GFH375X1101 study.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics  Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL9sSv42:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595"],"gpt_icon":0},{"id":"2616877926","title":"Genfleet Therapeutics (Shanghai) - Gfh375 Granted First Breakthrough Therapy Designation in China for a-Kras G12d Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2616877926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616877926?lang=en_us&edition=fundamental","pubTime":"2026-03-02 08:01","pubTimestamp":1772409673,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZO04A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02595","BK1161"],"gpt_icon":0},{"id":"1171806203","title":"GenFleet (2595) Included in Key Hang Seng and MSCI Indices","url":"https://stock-news.laohu8.com/highlight/detail?id=1171806203","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171806203?lang=en_us&edition=fundamental","pubTime":"2026-02-13 22:45","pubTimestamp":1770993919,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 2595) announced that it will be added to multiple Hang Seng Index Series and the MSCI Global Small Cap Index. According to the quarter-end review by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"1152823816","title":"GENFLEET-B (02595) Added to Hang Seng and MSCI Index Series","url":"https://stock-news.laohu8.com/highlight/detail?id=1152823816","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152823816?lang=en_us&edition=fundamental","pubTime":"2026-02-13 22:30","pubTimestamp":1770993000,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that, based on the quarterly review results released by Hang Seng Indexes Company Limited on February 13, 2026, the company has been selected as a constituent of the Hang...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109391861.USD","MCHmain","LU0175139822.USD","BK1574","513600","02833","IE00BKPKM429.USD","LU0708995401.HKD","LU0672654240.SGD","LU2210149790.SGD","LU2210150020.SGD","LU1691799644.USD","LU0320765059.SGD","LU2095319765.USD","LU0289960550.SGD","LU1267930730.SGD","BK4112","BK1515","LU0511384066.AUD","LU0390134368.USD","LU0289961442.SGD","LU1804176565.USD","HHImain","BK4588","BK4585","LU2265009873.SGD","02595","LU0289739343.SGD","BK1161"],"gpt_icon":0},{"id":"2611680131","title":"GenFleet Therapeutics Joins Hang Seng and MSCI Indices","url":"https://stock-news.laohu8.com/highlight/detail?id=2611680131","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611680131?lang=en_us&edition=fundamental","pubTime":"2026-02-13 22:23","pubTimestamp":1770992580,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics  Inc. will be added as a constituent to several indices, including the Hang Seng Composite Index, Hang Seng Stock Connect Hong Kong Index, Hang Seng Innovative Drug Index, and the MSCI Global Small Cap Index. The additions follow the latest quarterly review results and reflect investors' recognition of the company's sustained value and potential.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics  Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL6tB98d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161"],"gpt_icon":0},{"id":"1133787881","title":"Short Sale List Update Takes Effect Today with 51 Additions Including GenFleet-B","url":"https://stock-news.laohu8.com/highlight/detail?id=1133787881","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133787881?lang=en_us&edition=fundamental","pubTime":"2026-02-13 07:42","pubTimestamp":1770939768,"startTime":"0","endTime":"0","summary":"The Hong Kong Exchanges and Clearing Limited revised its list of designated securities eligible for short selling on February 10, with the changes becoming effective today. According to the latest...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159938","BK1240","BK1515","BK1555","00662","02595","BK1136","BK1161","BK1574","02777"],"gpt_icon":0},{"id":"1113739273","title":"GenFleet Therapeutics (Shanghai) Inc. Announces Revised Articles of Association","url":"https://stock-news.laohu8.com/highlight/detail?id=1113739273","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113739273?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:43","pubTimestamp":1770648209,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (referred to below as GenFleet Inc.) has released its updated Articles of Association. This revision was considered and approved at an extraordinary general...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"1108474521","title":"GenFleet (2595) Passes All Resolutions at EGM and Abolishes Supervisory Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1108474521","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108474521?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:43","pubTimestamp":1770648194,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 2595) held an extraordinary general meeting (EGM) on February 9, 2026. According to the announcement, the EGM was legally and validly convened at...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"2610560956","title":"GenFleet Therapeutics Held Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2610560956","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610560956?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:26","pubTimestamp":1770647216,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics  Inc. held an extraordinary general meeting on February 9, 2026. Shareholders approved the abolishment of the Supervisory Committee and amendments to the Articles of Association.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics  Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL6zjXKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161"],"gpt_icon":0},{"id":"1132125759","title":"BOCOM International Forecasts Continued Stable Growth for Healthcare Sector This Year, Recommends Seeking Undervalued Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1132125759","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132125759?lang=en_us&edition=fundamental","pubTime":"2026-02-05 17:16","pubTimestamp":1770282992,"startTime":"0","endTime":"0","summary":"The Hang Seng Healthcare Index declined 3.3% this week, underperforming the broader market. Since the fourth quarter of last year, the proportion of mainland capital holding pharmaceutical stocks...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1141","SG9999014674.SGD","159938","HK0000165453.HKD","BK1593","BK1191","BK1574","01530","03329","09939","BK1147","00013","BK1515","LU2488822045.USD","BK1588","BK1583","BK1587","02595","02268"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genfleet.com","stockEarnings":[{"period":"1week","weight":0.1721},{"period":"1month","weight":-0.069},{"period":"3month","weight":0.044},{"period":"6month","weight":0.4429},{"period":"ytd","weight":0.2372}],"compareEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":-0.066},{"period":"3month","weight":-0.0197},{"period":"6month","weight":-0.035},{"period":"1year","weight":0.0854},{"period":"ytd","weight":-0.0064}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"GenFleet Therapeutics (Shanghai) Inc is a China-based company principally engaged in the development of innovative drugs. The Company provides effective new treatment solutions for tumors, autoimmune and inflammatory diseases, covering target discovery, molecular discovery and evaluation, translational science and clinical development, as well as key chemistry manufacturing and controls aspects including formulation research, process development and quality analysis. The Company is mainly engaged in the development of new molecular entities, novel molecular modalities, investigation of molecular process routes and quality standards, and exploration of differentiated clinical development strategies and paths. The Company mainly primarily operates in the domestic and international markets.","exchange":"SEHK","name":"GENFLEET-B","nameEN":"GENFLEET-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GENFLEET-B(02595),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GENFLEET-B(02595) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GENFLEET-B,02595,GENFLEET-B股票,GENFLEET-B股票老虎,GENFLEET-B股票老虎国际,GENFLEET-B行情,GENFLEET-B股票行情,GENFLEET-B股价,GENFLEET-B股市,GENFLEET-B股票价格,GENFLEET-B股票交易,GENFLEET-B股票购买,GENFLEET-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GENFLEET-B(02595),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GENFLEET-B(02595) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}